Primary extragonadal germ cell tumours: Real‐world data from a high‐volume centre
BJUI Compass · 2026-04 · 7 (4)
DOI: 10.1002/bco2.70202 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJUI Compass, online erschienen am 16.04.2026. Verfasst von Marc Kidess und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology LMU University Hospital of Munich Munich Germany. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To provide improved evidence for treatment recommendations, this study analysed real‐world data on the characteristics, treatment and prognosis of primary extragonadal germ cell tumours (EGCTs), a very rare cancer entity that shares histological features with testicular GCTs (TGCT). Materials and methods This retrospective study analysed data from 34 patients with mediastinal or retroperitoneal EGCTs treated at a high‐volume centre between 2015 and 2025. Probability of overall survival (OS) and relapse‐free survival (RFS) was assessed using Kaplan–Meier curves.
Results
A primary retroperitoneal and primary mediastinal GCT was diagnosed in 23 (68%) and 11 (32%) patients, respectively. Median patient age was 41.1 years, and 62% were non‐seminomatous in origin. Thirty‐three (97%) patients received chemotherapy according to the IGCCCG prognostic group, and 15 (44%) underwent surgical intervention (4 primary RPLND, 8 post‐chemotherapy RPLND, 3 secondary orchiectomy). Thirteen patients (44.9%) who completed chemotherapy experienced a relapse after a median of 0.79 years, and six of them died. In patients with primary mediastinal seminoma, 3‐year RFS and OS were 100% as compared to 71% 3‐year OS in patients with primary retroperitoneal non‐seminoma and 46% 3‐year RFS in patients with primary mediastinal non‐seminoma.
Conclusion
The prognosis for primary mediastinal seminoma appears favourable, while non‐seminomatous EGCT shows poorer outcomes. Additionally, primary retroperitoneal seminomas demonstrate promising survival rates, whereas primary retroperitoneal non‐seminomas demonstrate the lowest OS rates.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology LMU University Hospital of Munich Munich Germany.
- Department of Medicine III Red Cross Hospital Munich Munich Germany.
- School of Computation, Information and Technology Technical University of Munich Munich Germany.
ORCID-Profile: Marc Kidess, Yannic Volz, Benedikt Ebner, Maria Apfelbeck, Michael Chaloupka
Zitieren
APA
Kidess, M., Hentrich, M., Aschl, F., Chernova, O., Beckstein, S., Bojko, P., Schulz, S., Neitz, J., Hermans, J., Volz, Y., Ebner, B., Keller, P., Apfelbeck, M., Marcon, J., Weinhold, P., Stief, C. G., Eismann, L., & Chaloupka, M. (2026). Primary extragonadal germ cell tumours: Real‐world data from a high‐volume centre. BJUI Compass, 7(4). https://doi.org/10.1002/bco2.70202
Vancouver
Kidess M, Hentrich M, Aschl F, Chernova O, Beckstein S, Bojko P, et al. Primary extragonadal germ cell tumours: Real‐world data from a high‐volume centre. BJUI Compass. 2026;7(4). doi:10.1002/bco2.70202
BibTeX
@article{Kidess2026,
author = {Kidess, Marc and Hentrich, Marcus and Aschl, Franz and Chernova, Oksana and Beckstein, Sebastian and Bojko, Peter and Schulz, Sebastian and Neitz, Julia and Hermans, Julian and Volz, Yannic and Ebner, Benedikt and Keller, Patrick and Apfelbeck, Maria and Marcon, Julian and Weinhold, Philipp and Stief, Christian G and Eismann, Lennert and Chaloupka, Michael},
title = {Primary extragonadal germ cell tumours: Real‐world data from a high‐volume centre},
journal = {BJUI Compass},
year = {2026},
volume = {7},
number = {4},
doi = {10.1002/bco2.70202}
}
EUVIMED